Oxytocin reverses osteoporosis in a sex-dependent manner

Frontiers in Endocrinology

Volumn 6, Issue MAY, 2015, Pages

  Beranger, Guillaume E ^a,b   Djedaini, Mansour ^a,b   Battaglia, Séverine ^c,d   Roux, Christian H ^a,b,e   Scheideler, Marcel ^f,g,h   Heymann, Dominique ^c,d   Amri, Ez Zoubir ^a,b   Pisani, Didier F ^a,b  

^a CENTRE DE BIOCHIMIE   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d INSERM   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

Adipose tissue; Bone; Female; Male; Mice; Orchidectomy

Indexed keywords

MOLECULAR MARKER; OLIGONUCLEOTIDE; OSTEOCALCIN; OXYTOCIN;

ADIPOSE TISSUE; ANDROPAUSE; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFICACY; FAT MASS; FEMALE; GENDER; GENE EXPRESSION; GENETIC ANALYSIS; MALE; METAPHYSIS; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MUSCLE ATROPHY; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; ORCHIECTOMY; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TRABECULAR BONE; WEIGHT REDUCTION;

EID: 84930941527     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2015.00081     Document Type: Article

References (39)

1. Cauley JA. Estrogen and bone health in men and women. Steroids (2014). doi: 10.1016/j.steroids.2014.12.010
2. Giusti A, Bianchi G. Treatment of primary osteoporosis in men. Clin Interv Aging (2014) 10:105-15. doi:10.2147/CIA.S44057
3. Raisz LG, Rodan AG. Pathogenesis of osteoporosis. Endocrinol Metab Clin North Am (2003) 32(1):15-24. doi:10.1016/S0889-8529(02)00055-5
4. Cooper C, Campion G, Melton JL III. Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 2(6):285-9. doi:10.1007/BF01623184
5. Cunningham GR. Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels. Endocr Pract (2013) 19(5):847-52. doi:10.4158/EP13217.RA
6. Daniell HW. Osteoporosis after orchiectomy for prostate cancer. J Urol (1997) 157(2):439-44. doi:10.1016/S0022-5347(01)65165-6
7. Chan GK, Duque G. Age-related bone loss: old bone, new facts. Gerontology (2002) 48(2):62-71. doi:10.1159/000048929
8. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest (2005) 115(12):3318-25. doi:10.1172/JCI27071
9. Karsenty G, Wagner FE. Reaching a genetic and molecular understanding of skeletal development. Dev Cell (2002) 2(4):389-406. doi:10.1016/S1534-5807(02)00157-0
10. Seeman E, Delmas DP. Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med (2006) 354(21):2250-61. doi:10.1056/NEJMra053077
11. Rodan GA, Martin JT. Therapeutic approaches to bone diseases. Science (2000) 289(5484):1508-14. doi:10.1126/science.289.5484.1508
12. Teitelbaum SL. Bone resorption by osteoclasts. Science (2000) 289(5484):1504-8. doi:10.1126/science.289.5484.1504
13. Rosen CJ, Bouxsein LM. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol (2006) 2(1):35-43. doi:10.1038/ncprheum0070
14. Elabd C, Basillais A, Beaupied H, Breuil V, Wagner N, Scheideler M, et al. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells (2008) 26(9):2399-407. doi:10.1634/stemcells.2008-0127
15. Breuil V, Amri EZ, Panaia-Ferrari P, Testa J, Elabd C, Albert-Sabonnadière C, et al. Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition. Joint Bone Spine (2011) 78(6):611-5. doi:10.1016/j.jbspin.2011.02.002
16. Breuil V, Panaia-Ferrari P, Fontas E, Roux C, Kolta S, Eastell R, et al. Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohort. J Clin Endocrinol Metab (2014) 99(4):E634-41. doi:10.1210/jc.2013-4126
17. Beranger GE, Pisani DF, Castel J, Djedaini M, Battaglia S, Amiaud J, et al. Oxytocin reverses ovariectomy-induced osteopenia and body fat gain. Endocrinology (2014) 155(4):1340-52. doi:10.1210/en.2013-1688
18. Smith JG, Merrill CD. Oxytocin for induction of labor. Clin Obstet Gynecol (2006) 49(3):594-608. doi:10.1097/00003081-200609000-00019
19. Elabd C, Cousin W, Upadhyayula P, Chen RY, Chooljian MS, Li J, et al. Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration. Nat Commun (2014) 5:4082. doi:10.1038/ncomms5082
20. Pisani DF, Djedaini M, Beranger GE, Elabd C, Scheideler M, Ailhaud G, et al. Differentiation of human adipose-derived stem cells into "brite" (brown-in-white) adipocytes. Front Endocrinol (2011) 2:87. doi:10.3389/fendo.2011.00087
21. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab (1996) 81(12):4358-65. doi:10.1210/jc.81.12.4358
22. Riggs BL, Parfitt MA. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res (2005) 20(2):177-84. doi:10.1359/JBMR.041114
23. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab (1997) 82(2):407-13. doi:10.1210/jcem.82.2.3733
24. Erben RG, Eberle J, Stahr K, Goldberg M. Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study. J Bone Miner Res (2000) 15(6):1085-98. doi:10.1359/jbmr.2000.15.6.1085
25. Vanderschueren D, Vandenput L, Boonen S, Van Herck E, Swinnen JV, Bouillon R. An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement. Endocrinology (2000) 141(5):1642-7. doi:10.1210/en.141.5.1642
26. Maejima Y, Iwasaki Y, Yamahara Y, Kodaira M, Sedbazar U, Yada T. Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging (Albany NY) (2011) 3(12):1169-77.
27. Tamma R, Colaianni G, Zhu LL, DiBenedetto A, Greco G, Montemurro G, et al. Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A (2009) 106(17):7149-54. doi:10.1073/pnas.0901890106
28. Most W, van der Wee-Pals L, Ederveen A, Papapoulos S, Löwik C. Ovariectomy and orchidectomy induce a transient increase in the osteoclastogenic potential of bone marrow cells in the mouse. Bone (1997) 20(1):27-30. doi:10.1016/S8756-3282(96)00309-2
29. Turner RT, Wakley KG, Hannon SK. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J Orthop Res (1990) 8(4):612-7. doi:10.1002/jor.1100080418
30. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev (1994) 15(3):342-55. doi:10.1210/er.15.3.342
31. Matsumoto C, Inada M, Toda K, Miyaura C. Estrogen and androgen play distinct roles in bone turnover in male mice before and after reaching sexual maturity. Bone (2006) 38(2):220-6. doi:10.1016/j.bone.2005.08.019
32. Michael H, Härkönen PL, Väänänen HK, Hentunen TA. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res (2005) 20(12):2224-32. doi:10.1359/JBMR.050803
33. Onoe Y, Miyaura C, Ito M, Ohta H, Nozawa S, Suda T. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J Bone Miner Res (2000) 15(3):541-9. doi:10.1359/jbmr.2000.15.3.541
34. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, et al. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab (2002) 283(1):E154-64. doi:10.1152/ajpendo.00502.2001
35. Chambon C, Duteil D, Vignaud A, Ferry A, Messaddeq N, Malivindi R, et al. Myocytic androgen receptor controls the strength but not the mass of limb muscles. Proc Natl Acad Sci U S A (2010) 107(32):14327-32. doi:10.1073/pnas.1009536107
36. Katznelson L, Rosenthal DI, Rosol MS, Anderson EJ, Hayden DL, Schoenfeld DA, et al. Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism. AJR Am J Roentgenol (1998) 170(2):423-7. doi:10.2214/ajr.170.2.9456958
37. Mammi C, Calanchini M, Antelmi A, Cinti F, Rosano GM, Lenzi A, et al. Androgens and adipose tissue in males: a complex and reciprocal interplay. Int J Endocrinol (2012) 2012:789653. doi:10.1155/2012/789653
38. Blouin K, Boivin A, Tchernof A. Androgens and body fat distribution. J Steroid Biochem Mol Biol (2008) 108(3-5):272-80. doi:10.1016/j.jsbmb.2007.09.001
39. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med (1997) 337(2):91-5. doi:10.1056/NEJM199707103370204